Top in cardiology: Experts debate use of AI to improve cardiovascular medicine

In part one of a three-part Healio exclusive series, experts discussed the need for clinical guidance and evidence for the use of AI to improve cardiovascular outcomes.

Although AI has shown potential in areas such as cardiac imaging and ECG interpretation, the experts noted that there is an overall lack of outcomes data and interpretability.

“At the end of the day, as a clinician, if you have that outcome data, if you have those large, randomized trials that show that this saves lives, then I think most clinicians would probably be willing to sacrifice a little bit of interpretability about what the algorithm is doing as long as they know it works,” Shaan Khurshid, MD, MPH, a cardiac electrophysiologist at Massachusetts General Hospital and instructor of medicine at Harvard Medical School, told Healio.

It was the top story in cardiology last week.

Another top story includes part two of the Healio exclusive series, which focused on the importance of a successful data security and governance framework for the implementation of AI tools in clinical practice.

Read these and more top stories in cardiology below:

AI stands to change cardiology practice, but guidance, evidence of benefit are needed

Interest in the use and development of AI to not only improve outcomes but enhance day-to-day productivity is on the rise, and rigorously validated tools and clinical guidance are needed to best implement its use. Read more.

AI in cardiology: A call for robust validation, regulatory labeling and security of data

As the development of AI tools for use in clinical practice hastens, a successful framework for their useful, safe and equitable implementation remains paramount. Read more.

Bioadaptor may flatten event curve after PCI, including in complex lesions

A bioadaptor implant adaptable to vessel physiology was linked to fewer target lesion failure events after 6 months compared with a drug-eluting stent, including in high-risk lesions, researchers reported. Read more.

TAVR could be ‘preferred therapeutic option’ over surgery for women

Women with symptomatic severe aortic stenosis had better 1-year outcomes after transcatheter aortic valve replacement vs. surgery, according to a pooled analysis of only women in the PARTNER 3 low-risk and RHEIA trials. Read more.

Transcatheter tricuspid valve replacement effective treatment for severe regurgitation

In patients with severe tricuspid regurgitation, transcatheter tricuspid valve replacement plus medical therapy improved outcomes compared with medical therapy alone, researchers reported at TCT 2024. Read more.